Uterine rupture with induction using misoprostol for intrauterine foetal death in the second trimester: A case report.

IF 0.7 Q4 OBSTETRICS & GYNECOLOGY Case Reports in Women's Health Pub Date : 2024-11-30 eCollection Date: 2024-12-01 DOI:10.1016/j.crwh.2024.e00671
Akiko Yamamoto, Patrick Jn-Charles
{"title":"Uterine rupture with induction using misoprostol for intrauterine foetal death in the second trimester: A case report.","authors":"Akiko Yamamoto, Patrick Jn-Charles","doi":"10.1016/j.crwh.2024.e00671","DOIUrl":null,"url":null,"abstract":"<p><p>Uterine rupture is a well-known, life-threatening complication of misoprostol use; the incidence is remarkably low. Herein, we report what seems to be the first documented case of uterine rupture following induction of labour for intrauterine foetal death in the second trimester without a uterine scar. A 40-year-old woman with no history of caesarean section or uterine surgery presented with mild lower abdominal pain and mild genital bleeding. Transabdominal ultrasonography revealed intrauterine foetal death, at presumed gestational age of 20 weeks. Two hours after three doses of 400 μg 3-hourly of misoprostol, the patient complained of abdominal pain; however, the foetus was not expelled. Repeat sonography revealed the foetus in the abdominal cavity and fluid collection in the pelvis. Based on the probable diagnosis of uterine rupture, a laparotomy was performed. The intra-abdominal haemorrhage volume was approximately 250-300 ml. There was a linear rupture approximately 10 cm long on the posterior wall of the uterus, and as a consequence, a macerated and foetid foetus and part of the placenta were found in the abdominal cavity. A total hysterectomy was performed, and the patient was discharged three days after the intervention without any postoperative complications. In conclusion, while misoprostol is generally safe for second-trimester pregnancy termination, its use should be approached with caution and close monitoring in cases of uterine inflammation.</p>","PeriodicalId":9657,"journal":{"name":"Case Reports in Women's Health","volume":"44 ","pages":"e00671"},"PeriodicalIF":0.7000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11665375/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Case Reports in Women's Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.crwh.2024.e00671","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Uterine rupture is a well-known, life-threatening complication of misoprostol use; the incidence is remarkably low. Herein, we report what seems to be the first documented case of uterine rupture following induction of labour for intrauterine foetal death in the second trimester without a uterine scar. A 40-year-old woman with no history of caesarean section or uterine surgery presented with mild lower abdominal pain and mild genital bleeding. Transabdominal ultrasonography revealed intrauterine foetal death, at presumed gestational age of 20 weeks. Two hours after three doses of 400 μg 3-hourly of misoprostol, the patient complained of abdominal pain; however, the foetus was not expelled. Repeat sonography revealed the foetus in the abdominal cavity and fluid collection in the pelvis. Based on the probable diagnosis of uterine rupture, a laparotomy was performed. The intra-abdominal haemorrhage volume was approximately 250-300 ml. There was a linear rupture approximately 10 cm long on the posterior wall of the uterus, and as a consequence, a macerated and foetid foetus and part of the placenta were found in the abdominal cavity. A total hysterectomy was performed, and the patient was discharged three days after the intervention without any postoperative complications. In conclusion, while misoprostol is generally safe for second-trimester pregnancy termination, its use should be approached with caution and close monitoring in cases of uterine inflammation.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
米索前列醇诱导子宫破裂治疗妊娠中期宫内死胎1例。
子宫破裂是使用米索前列醇的一个众所周知的危及生命的并发症;发病率非常低。在这里,我们报告什么似乎是第一个记录的情况下,引产后宫内胎儿死亡宫内妊娠中期子宫破裂无子宫疤痕。女性,40岁,无剖宫产史,无子宫手术史。经腹超声检查显示胎儿宫内死亡,推测胎龄为20周。米索前列醇给药3次,每小时400 μg,服药2小时,患者主诉腹痛;然而,胎儿并没有被排出体外。重复超声显示胎儿在腹腔和骨盆积液。基于可能的诊断子宫破裂,进行剖腹手术。腹内出血量约250-300毫升。子宫后壁有一个约10厘米长的线状破裂,结果在腹腔内发现浸渍和腐臭的胎儿和部分胎盘。患者行全子宫切除术,干预3天后出院,无术后并发症。总之,虽然米索前列醇用于中期妊娠终止通常是安全的,但在子宫炎症的情况下应谨慎使用并密切监测。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Case Reports in Women's Health
Case Reports in Women's Health Medicine-Obstetrics and Gynecology
CiteScore
2.10
自引率
0.00%
发文量
89
审稿时长
7 days
期刊最新文献
Predicting outcomes with compounding comorbidities - Left-sided congenital diaphragmatic hernia complicated by pre-viable premature rupture of the membranes: A case report. Toxic shock syndrome secondary to Group A Streptococcus infection: A case report. Second-trimester uterine rupture in bicornuate uterus: A case report. Low-dose naltrexone as a treatment for vulvodynia: A case series. Prenatal diagnosis of clinodactyly and its association with genetic syndromes: A case report.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1